Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
The American Journal of Managed Care|September 7, 2007
Predicting HIV care costs using CD4 counts from clinical trialsAndrew Hill, Kelly Gebo
The Journal of Infectious Diseases|January 17, 2025
Mpox: What have we learned and how do we better prepare for the future?Seth D Judson, Chloe M Orkin, Kelly Gebo
AIDS Research and Treatment|March 28, 2013
Patterns of Use and Outcomes in Patients Treated with Etravirine in the HIV Research NetworkKelly Gebo, Cindy Voss, Joseph Mrus, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Natural History of Self-reported Symptoms Following SARS-CoV-2 Infection: A Target Trial Emulation in a Prospective Community-Based CohortYanhan Shen, Zach Shahn, McKaylee M Robertson, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Long COVID Longitudinal Symptoms Burden Clusters Within A National Community-Based CohortYanhan Shen, Zach Shahn, McKaylee M Robertson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 25, 2026
Natural History of Self-reported Symptoms Following SARS-CoV-2 Infection: A Target Trial Emulation in a Prospective Community-recruited CohortYanhan Shen, Zach Shahn, McKaylee M Robertson, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Effect of a Third COVID-19 Vaccine Dose on the Incidence of Long COVID Among Adults Who Completed a Primary Vaccine Series: a Target Trial Emulation in a Community-Based CohortYanhan Shen, Zach Shahn, McKaylee M Robertson, et al.
BMC Infectious Diseases|May 22, 2026
Long COVID longitudinal symptoms burden clusters within a national community-based cohortYanhan Shen, Zach Shahn, McKaylee M Robertson, et al.
Vaccine|May 8, 2026
Effect of a third COVID-19 vaccine dose on the incidence of Long COVID among adults who completed a primary vaccine series: a target trial emulation in a community-based cohortYanhan Shen, Zach Shahn, McKaylee M Robertson, et al.
Pharmacoeconomics|December 25, 2010
Predicting direct costs of HIV care during the first year of darunavir-based highly active antiretroviral therapy using CD4 cell counts: evidence from POWERAndrew M Hill, Kelly Gebo, Lindsay Hemmett, et al.
Pageof 5